EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark THERIVA was filed as Word mark on 07/08/2022 at the European Union Intellectual Property Office.
It was registered as a trademark on 11/15/2022.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018730146 |
| Application date | July 8, 2022 |
| Publication date | August 8, 2022 |
| Entry date | November 15, 2022 |
| Expiration date | July 8, 2032 |
Trademark owner
Suite 270, 9605 Medical Center Dr.
20850 Rockville
US
20850 Rockville
US
Trademark representatives
7 Rue Guimard
1040 Brussels
BE
goods and services
5
Pharmaceutical preparations for the treatment, prevention and alleviation of gastrointestinal diseases, infections, dysbiosis, and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders; Pharmaceuticals, namely, pharmaceutical preparations for gastrointestinal health, used to maintain health and restore health to a human or animal subject via treatment of a disturbed microbial community and prevention of microbial community disruption; Pharmaceuticals, namely, pharmaceutical preparations for gastrointestinal dysbiosis and systemic illnesses associated with gastrointestinal dysbiosis, used to maintain health and restore health to a human or animal subject via treatment of a disturbed microbial community and prevention of microbial community disruption; Pharmaceuticals, namely, pharmaceutical preparations for gastrointestinal disorders and systemic illnesses associated with gastrointestinal disorders, used to maintain health and restore health to a human or animal subject via treatment of a disturbed microbial community and prevention of microbial community disruption; Pharmaceuticals, namely, pharmaceutical preparations for gastrointestinal diseases and systemic illnesses associated with gastrointestinal diseases, used to maintain health and restore health to a human or animal subject via treatment of a disturbed microbial community and prevention of microbial community disruption; Pharmaceuticals, namely, pharmaceutical preparations for gastrointestinal infections and systemic illnesses associated with gastrointestinal infections, used to maintain health and restore health to a human or animal subject via treatment of a disturbed microbial community and prevention of microbial community disruption; Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; oncolytic viral therapies; biological therapies for use in the treatment of cancer and tumors
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| May 5, 2023 | Transfer / Change of address, Published | ||
| April 13, 2023 | Transfer / Change of address, Published | ||
| February 16, 2023 | Transfer / Change of address, Published |
ID: 11018730146